Skip to main content

Advertisement

SpringerLink
Log in

Photodynamic Therapy in Macular Diseases of Asian Populations: When East Meets West

  • CLINICAL INVESTIGATION
  • Published:
Japanese Journal of Ophthalmology Aims and scope Submit manuscript

Abstract

Purpose

We reviewed the indications, safety, and efficacy of photodynamic therapy with verteporfin in various macular diseases and vasculopathies, which are common in Asian populations, and compared the outcomes of photodynamic therapy in Asian patients with the outcomes in Caucasian patients.

Methods

Relevant clinical and laboratory original articles, case reports, and review articles that have been published in the literature between January 1999 and October 2004 were searched in Medline. The potential differences in the response to photodynamic therapy between Asian and Caucasian patients were evaluated. Articles in foreign languages with English abstracts were included.

Results

Macular diseases commonly seen in Asian populations, including choroidal neovascularization (CNV) of age-related macular degeneration, secondary to pathologic myopia or from an idiopathic cause, and choroidal vasculopathies such as central serous chorioretinopathy and polypoidal choroidal vasculopathy were included in the review. The results were tabulated and the differences with Caucasian populations were compared and highlighted.

Conclusion

Photodynamic therapy has been found to be an effective and noninvasive treatment for various subfoveal CNV and choroidal vasculopathies of the macula. Diverse behavior in different ethnic groups is observed. Jpn J Ophthalmol 2006;50:161–169 © Japanese Ophthalmological Society 2006

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. NM Bressler InstitutionalAuthorNameTreatment of Age-Related Macular Degeneration with Photodynamic Therapy (TAP) Study Group (2001) ArticleTitlePhotodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: two-year results of two randomized clinical trials—TAP report 2 Arch Ophthalmol 119 198–207 Occurrence Handle11176980 Occurrence Handle1:CAS:528:DC%2BD3MXhsVCkurs%3D

    PubMed  CAS  Google Scholar 

  2. InstitutionalAuthorNameVerteporfin in Photodynamic Therapy Study Group (2001) ArticleTitlePhotodynamic therapy of subfoveal choroidal neovascularization in pathologic myopia with verteporfin. 1-year results of a randomized clinical trial—VIP report No. 1 Ophthalmology 108 841–852

    Google Scholar 

  3. InstitutionalAuthorNameVerteporfin in Photodynamic Therapy Study Group (2001) ArticleTitleVerteporfin therapy of subfoveal choroidal neovascularization in age-related macular degeneration: two-year results of a randomized clinical trial including lesions with occult with no classic choroidal neovascularization—verteporfin in photodynamic therapy. Report 2 Am J Ophthalmol 131 541–560

    Google Scholar 

  4. InstitutionalAuthorNameTreatment of Age-related Macular Degeneration with Photodynamic Therapy (TAP) Study Group (1999) ArticleTitlePhotodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin. One-year results of two randomized clinical trials—TAP Report 1 Arch Ophthalmol 117 1329–1345

    Google Scholar 

  5. LA Yannuzzi JS Slakter NE Gross et al. (2003) ArticleTitleIndocyanine green angiography-guided photodynamic therapy for treatment of chronic central serous chorioretinopathy: a pilot study Retina 23 288–298 Occurrence Handle10.1097/00006982-200312001-00003 Occurrence Handle12824827

    Article  PubMed  Google Scholar 

  6. WM Chan DS Lam TY Lai BS Tam DT Liu CK Chan (2003) ArticleTitleChoroidal vascular remodelling in central serous chorioretinopathy after indocyanine green guided photodynamic therapy with verteporfin: a novel treatment at the primary disease level Br J Ophthalmol 87 1453–1458 Occurrence Handle14660450

    PubMed  Google Scholar 

  7. RF Spaide I Donsoff DL Lam et al. (2002) ArticleTitleTreatment of polypoidal choroidal vasculopathy with photodynamic therapy Retina 22 529–535 Occurrence Handle12441716

    PubMed  Google Scholar 

  8. WM Chan DS Lam TY Lai et al. (2004) ArticleTitlePhotodynamic therapy with verteporfin for symptomatic polypoidal choroidal vasculopathy: one-year result of a prospective case series Ophthalmology 111 1576–1584 Occurrence Handle15288991

    PubMed  Google Scholar 

  9. M Uyama M Wada Y Nagai et al. (2002) ArticleTitlePolypoidal choroidal vasculopathy: natural history Am J Ophthalmol 133 639–648 Occurrence Handle10.1016/S0002-9394(02)01404-6 Occurrence Handle11992861

    Article  PubMed  Google Scholar 

  10. AK Kwok TY Lai CW Chan et al. (2002) ArticleTitlePolypoidal choroidal vasculopathy in Chinese patients Br J Ophthalmol 86 892–897 Occurrence Handle12140211 Occurrence Handle1:STN:280:DC%2BD38zptFCguw%3D%3D

    PubMed  CAS  Google Scholar 

  11. M Uyama K Takahashi N Ida M Miyashiro et al. (2000) ArticleTitleThe second eye of Japanese patients with unilateral exudative age-related macular degeneration Br J Ophthalmol 84 1018–1023 Occurrence Handle10.1136/bjo.84.9.1018 Occurrence Handle10966957 Occurrence Handle1:STN:280:DC%2BD3cvotVKgsw%3D%3D

    Article  PubMed  CAS  Google Scholar 

  12. JI Lim A Kwok DK Wilson (1998) ArticleTitleSymptomatic age-related macular degeneration in Asian patients Retina 18 435–438 Occurrence Handle9801039 Occurrence Handle1:STN:280:DyaK1M%2FhsFKmug%3D%3D

    PubMed  CAS  Google Scholar 

  13. K Sho K Takahashi H Yamada et al. (2003) ArticleTitlePolypoidal choroidal vasculopathy: incidence, demographic features, and clinical characteristics Arch Ophthalmol 121 1392–1396 Occurrence Handle10.1001/archopht.121.10.1392 Occurrence Handle14557174

    Article  PubMed  Google Scholar 

  14. D Husain JW Miller N Michaud E Connolly TJ Flotte ES Gragoudas (1996) ArticleTitleIntravenous infusion of liposomal benzoporphyrin derivative for photodynamic therapy of experimental choroidal neovascularization Arch Ophthalmol 114 978–985 Occurrence Handle8694734 Occurrence Handle1:CAS:528:DyaK28XltFOitrY%3D

    PubMed  CAS  Google Scholar 

  15. JW Miller U Schmidt-Erfurth M Sickenberg et al. (1999) ArticleTitlePhotodynamic therapy with verteporfin for choroidal neovascularization caused by age-related macular degeneration: results of a single treatment in a phase 1 and 2 study Arch Ophthalmol 117 1161–1173 Occurrence Handle10496388 Occurrence Handle1:CAS:528:DyaK1MXmsVantr4%3D

    PubMed  CAS  Google Scholar 

  16. MF Shuler JL Borrillo AC Ho (2001) ArticleTitlePhotodynamic therapy update Curr Opin Ophthalmol 12 202–206 Occurrence Handle10.1097/00055735-200106000-00010 Occurrence Handle11389347 Occurrence Handle1:STN:280:DC%2BD3Mzhs1emtA%3D%3D

    Article  PubMed  CAS  Google Scholar 

  17. U Schmidt-Erfurth T Hasan (2000) ArticleTitleMechanisms of action of photodynamic therapy with verteporfin for the treatment of age-related macular degeneration Surv Ophthalmol 45 195–214 Occurrence Handle11094244 Occurrence Handle1:STN:280:DC%2BD3M7gslKjsA%3D%3D

    PubMed  CAS  Google Scholar 

  18. RW Flower (1999) ArticleTitleExpanded hypothesis on the mechanism of photodynamic therapy action on choroidal neovascularization Retina 19 365–369 Occurrence Handle10546929 Occurrence Handle1:STN:280:DC%2BD3c%2Fht1Chsg%3D%3D

    PubMed  CAS  Google Scholar 

  19. AM Richter S Cerruti-Sola ED Sternberg D Dolphin JG Levy (1990) ArticleTitleBiodistribution of tritiated benzoporphyrin derivative (3H-BPD-MA), a new potent photosensitizer in normal and tumor-bearing mice J Photochem Photobiol B 5 231–244 Occurrence Handle10.1016/1011-1344(90)80008-L Occurrence Handle2111398 Occurrence Handle1:CAS:528:DyaK3cXltFWltbs%3D

    Article  PubMed  CAS  Google Scholar 

  20. JC Maziere P Morliere R Santus (1991) ArticleTitleThe role of the low density lipoprotein receptor pathway in the delivery of lipophilic photosensitizers in the photodynamic therapy of tumours J Photochem Photobiol B 8 351–360 Occurrence Handle1904487 Occurrence Handle1:CAS:528:DyaK3MXhvVWhu7Y%3D

    PubMed  CAS  Google Scholar 

  21. VH Fingar (1996) ArticleTitleVascular effects of photodynamic therapy J Clin Laser Med Surg 14 323–328 Occurrence Handle9612199 Occurrence Handle1:STN:280:DyaK1c3nsFWntA%3D%3D

    PubMed  CAS  Google Scholar 

  22. DJ Granville BM McManus DW Hunt (2001) ArticleTitlePhotodynamic therapy: shedding light on the biochemical pathways regulating porphyrin-mediated cell death Histol Histopathol 16 309–317 Occurrence Handle11193207 Occurrence Handle1:CAS:528:DC%2BD3MXhsVyltrw%3D

    PubMed  CAS  Google Scholar 

  23. U Schlotzer-Schrehardt A Viestenz GO Naumann H Laqua S Michels U Schmidt-Erfurth (2002) ArticleTitleDose-related structural effects of photodynamic therapy on choroidal and retinal structures of human eyes Graefes Arch Clin Exp Ophthalmol 240 748–757 Occurrence Handle12271373

    PubMed  Google Scholar 

  24. U Schmidt-Erfurth H Laqua U Schlotzer-Schrehardt A Viestenz GO Naumann (2002) ArticleTitleHistopathological changes following photodynamic therapy in human eyes Arch Ophthalmol 120 835–844 Occurrence Handle12049594

    PubMed  Google Scholar 

  25. M Uyama (1991) ArticleTitleChoroidal neovascularization, experimental and clinical study Nippon Ganka Gakkai Zasshi (Acta Soc Ophthalmol Jpn) 95 1145–1180 Occurrence Handle1:STN:280:By2C3szkvVE%3D

    CAS  Google Scholar 

  26. M Yuzawa K Hagita T Egawa H Minato M Matsui (1991) ArticleTitleMacular lesions predisposing to senile disciform macular degeneration Jpn J Ophthalmol 35 87–95 Occurrence Handle1716707 Occurrence Handle1:STN:280:By6A2svosFQ%3D

    PubMed  CAS  Google Scholar 

  27. InstitutionalAuthorNameJapanese Age-Related Macular Degeneration Trial (JAT) Study Group (2003) ArticleTitleJapanese age-related macular degeneration trial: 1-year results of photodynamic therapy with verteporfin in Japanese patients with subfoveal choroidal neovascularization secondary to age-related macular degeneration Am J Ophthalmol 136 1049–1061

    Google Scholar 

  28. K Ohno-Matsui T Yoshida (2004) ArticleTitleMyopic choroidal neovascularization: natural course and treatment Curr Opin Ophthalmol 15 197–202 Occurrence Handle15118506

    PubMed  Google Scholar 

  29. T Yoshida K Ohno-Matsui K Yasuzumi et al. (2003) ArticleTitleMyopic choroidal neovascularization: a 10-year follow-up Ophthalmology 110 1297–1305 Occurrence Handle12867382

    PubMed  Google Scholar 

  30. Y Tano (2002) ArticleTitlePathologic myopia: where are we now? Am J Ophthalmol 134 645–660 Occurrence Handle10.1016/S0002-9394(02)01883-4 Occurrence Handle12429239

    Article  PubMed  Google Scholar 

  31. RD Sperduto D Seigel J Roberts M Rowland (1983) ArticleTitlePrevalence of myopia in the United States Arch Ophthalmol 101 405–407 Occurrence Handle6830491 Occurrence Handle1:STN:280:BiyC2M3ktVQ%3D

    PubMed  CAS  Google Scholar 

  32. TY Wong PJ Foster J Hee et al. (2000) ArticleTitlePrevalence and risk factors for refractive errors in adult Chinese in Singapore Invest Ophthalmol Vis Sci 41 2486–2494 Occurrence Handle10937558 Occurrence Handle1:STN:280:DC%2BD3czps1WqsQ%3D%3D

    PubMed  CAS  Google Scholar 

  33. HE Grossniklaus WR Green (1992) ArticleTitlePathologic findings in pathologic myopia Retina 12 127–133 Occurrence Handle1439243 Occurrence Handle1:STN:280:ByyD28jlvVY%3D

    PubMed  CAS  Google Scholar 

  34. KJ Blinder MS Blumenkranz NM Bressler et al. (2003) ArticleTitleVerteporfin therapy of subfoveal choroidal neovascularization in pathologic myopia: 2-year results of a randomized clinical trial—VIP. Report no. 3 Ophthalmology 110 667–673 Occurrence Handle12689884

    PubMed  Google Scholar 

  35. DS Lam WM Chan DT Liu DS Fan WW Lai KK Chong (2004) ArticleTitlePhotodynamic therapy with verteporfin for subfoveal choroidal neovascularization of pathologic myopia in Chinese eyes—a prospective series of one- and two-years follow-up Br J Ophthalmol 88 1315–1319 Occurrence Handle10.1136/bjo.2004.041624 Occurrence Handle15377558 Occurrence Handle1:STN:280:DC%2BD2cvms12luw%3D%3D

    Article  PubMed  CAS  Google Scholar 

  36. M Secretan D Kuhn G Soubrane G Coscas (1997) ArticleTitleLong-term visual outcome of choroidal neovascularization in pathologic myopia: natural history and laser treatment Eur J Ophthalmol 7 307–316 Occurrence Handle9457451 Occurrence Handle1:STN:280:DyaK1c7hvVOktQ%3D%3D

    PubMed  CAS  Google Scholar 

  37. Y Oshima S Harino Y Tano (1998) ArticleTitleScanning laser ophthalmoscope microperimetric assessment in patients with successful laser treatment for juxtafoveal choroidal neovascularization Retina 18 109–117 Occurrence Handle9564690 Occurrence Handle1:STN:280:DyaK1c3isFykug%3D%3D

    PubMed  CAS  Google Scholar 

  38. JM Ruiz-Moreno JA Montero (2002) ArticleTitleLong-term visual acuity after argon green laser photocoagulation of juxtafoveal choroidal neovascularization in highly myopic eyes Eur J Ophthalmol 12 117–122 Occurrence Handle12022283 Occurrence Handle1:STN:280:DC%2BD383otlamuw%3D%3D

    PubMed  CAS  Google Scholar 

  39. DP Joseph A Uemura MA Thomas (2003) ArticleTitleSubretinal surgery for juxtafoveal choroidal neovascularization Retina 23 463–468 Occurrence Handle12972755

    PubMed  Google Scholar 

  40. SY Cohen A Bulik L Dubois G Quentel (2003) ArticleTitlePhotodynamic therapy for juxtafoveal choroidal neovascularization in myopic eyes Am J Ophthalmol 136 371–374 Occurrence Handle10.1016/S0002-9394(03)00201-0 Occurrence Handle12888071

    Article  PubMed  Google Scholar 

  41. DS Lam DT Liu DS Fan WW Lai SS So WM Chan (2005) ArticleTitlePhotodynamic therapy with verteporfin for juxtafoveal choroidal neovascularization secondary to pathologic myopia: one-year results of a prospective series Eye 19 834–840 Occurrence Handle15375364 Occurrence Handle1:CAS:528:DC%2BD2MXntVWjsro%3D

    PubMed  CAS  Google Scholar 

  42. AP Ciardella IM Donsoff SJ Huang DL Costa LA Yannuzzi (2004) ArticleTitlePolypoidal choroidal vasculopathy Surv Ophthalmol 49 25–37 Occurrence Handle14711438

    PubMed  Google Scholar 

  43. CW Spraul HE Grossniklaus GK Lang (1997) ArticleTitleIdiopathic polypoidal choroidal vasculopathy Klin Monatsbl Augenheilkd 210 405–406 Occurrence Handle9333671 Occurrence Handle1:STN:280:ByiH3cbms1w%3D

    PubMed  CAS  Google Scholar 

  44. M Quaranta M Mauget-Faysse G Coscas (2002) ArticleTitleExudative idiopathic polypoidal choroidal vasculopathy and photodynamic therapy with verteporfin Am J Ophthalmol 134 277–280 Occurrence Handle10.1016/S0002-9394(02)01516-7 Occurrence Handle12140043

    Article  PubMed  Google Scholar 

  45. AH Rogers PB Greenberg A Martidis CA Puliafito (2003) ArticleTitlePhotodynamic therapy of polypoidal choroidal vasculopathy Ophthalmic Surg Lasers Imaging 34 60–63 Occurrence Handle12570008

    PubMed  Google Scholar 

  46. C Torron Fernandez-Blanco S Perez Olivan E Ferrer Novella O Ruiz-Moreno B Marcuello Melendo FM Honrubia Lopez (2003) ArticleTitlePhotodynamic therapy for choroidal neovascularization not caused by age-related macular degeneration or pathologic myopia Arch Soc Esp Oftalmol 78 471–476 Occurrence Handle14517732 Occurrence Handle1:STN:280:DC%2BD3svlsFaksg%3D%3D

    PubMed  CAS  Google Scholar 

  47. SC Lee YS Seong SS Kim HJ Koh OW Kwon (2004) ArticleTitlePhotodynamic therapy with verteporfin for polypoidal choroidal vasculopathy of the macula Ophthalmologica 218 193–201 Occurrence Handle10.1159/000076844 Occurrence Handle15103216 Occurrence Handle1:CAS:528:DC%2BD2cXjt12rs7k%3D

    Article  PubMed  CAS  Google Scholar 

  48. BA Lafaut AM Leys B Snyers et al. (2000) ArticleTitlePolypoidal choroidal vasculopathy in Caucasians Graefes Arch Clin Exp Ophthalmol 238 752–759 Occurrence Handle10.1007/s004170000180 Occurrence Handle11045343 Occurrence Handle1:STN:280:DC%2BD3cvpvF2ltw%3D%3D

    Article  PubMed  CAS  Google Scholar 

  49. M Yuzawa R Mori M Haruyama (2003) ArticleTitleA study of laser photocoagulation for polypoidal choroidal vasculopathy Jpn J Ophthalmol 47 379–384 Occurrence Handle10.1016/S0021-5155(03)00042-X Occurrence Handle12842207

    Article  PubMed  Google Scholar 

  50. AC Ho LA Yannuzzi K Pisicano J DeRosa (1995) ArticleTitleThe natural history of idiopathic subfoveal choroidal neovascularization Ophthalmology 102 782–789 Occurrence Handle7539905 Occurrence Handle1:STN:280:ByqB1Mngs1A%3D

    PubMed  CAS  Google Scholar 

  51. B Lindblom T Andersson (1998) ArticleTitleThe prognosis of idiopathic choroidal neovascularization in persons younger than 50 years of age Ophthalmology 105 1816–1820 Occurrence Handle10.1016/S0161-6420(98)91021-1 Occurrence Handle9787348 Occurrence Handle1:STN:280:DyaK1M%2FgtlKitA%3D%3D

    Article  PubMed  CAS  Google Scholar 

  52. M Sickenberg U Schmidt-Erfurth JW Miller et al. (2000) ArticleTitleA preliminary study of photodynamic therapy using verteporfin for choroidal neovascularization in pathologic myopia, ocular histoplasmosis syndrome, angioid streaks, and idiopathic causes Arch Ophthalmol 118 327–336 Occurrence Handle10721954 Occurrence Handle1:CAS:528:DC%2BD3cXit1aksb8%3D

    PubMed  CAS  Google Scholar 

  53. RF Spaide ML Martin J Slakter et al. (2002) ArticleTitleTreatment of idiopathic subfoveal choroidal neovascular lesions using photodynamic therapy with verteporfin Am J Ophthalmol 134 62–68 Occurrence Handle10.1016/S0002-9394(02)01452-6 Occurrence Handle12095809 Occurrence Handle1:CAS:528:DC%2BD38XkvFGlurY%3D

    Article  PubMed  CAS  Google Scholar 

  54. AH Rogers JS Duker N Nichols BJ Baker (2003) ArticleTitlePhotodynamic therapy of idiopathic and inflammatory choroidal neovascularization Ophthalmology 110 1315–1320 Occurrence Handle10.1016/S0161-6420(03)00466-4 Occurrence Handle12867384

    Article  PubMed  Google Scholar 

  55. J Wachtlin A Wehner H Heimann MH Foerster (2004) ArticleTitlePhotodynamic treatment with verteporfin for patients with idiopathic choroidal neovascularization. Two-year results Ophthalmologe 101 489–495 Occurrence Handle10.1007/s00347-004-0993-5 Occurrence Handle15042402 Occurrence Handle1:CAS:528:DC%2BD2cXjs1yksr0%3D

    Article  PubMed  CAS  Google Scholar 

  56. WM Chan DS Lam TH Wong et al. (2003) ArticleTitlePhotodynamic therapy with verteporfin for subfoveal idiopathic choroidal neovascularization: one-year results from a prospective case series Ophthalmology 110 2395–2402 Occurrence Handle14644724

    PubMed  Google Scholar 

  57. JD Gass (1967) ArticleTitlePathogensis of disciform detachment of neuroepithelium: II. Idiopathic central serous chorioretinopathy Am J Ophthalmol 63 587–615

    Google Scholar 

  58. LS Hall DR Guyer LA Yannuzzi (1999) Central serous chorioretinopathy DR Guyer (Eds) et al. Retina–Vitreous–Macula WB Saunders Philadelphia 206–216

    Google Scholar 

  59. R Levine A Brucker F Robinson (1984) ArticleTitleLong-term follow-up of idiopathic central serous chorioretinopathy by fluorescein angiography Ophthalmology 91 1544–1548

    Google Scholar 

  60. RH Loo IU Scott HW Flynn SuffixJr et al. (2002) ArticleTitleFactors associated with reduced visual acuity during long-term follow-up of patients with idiopathic central serous chorioretinopathy Retina 22 19–24 Occurrence Handle11884873

    PubMed  Google Scholar 

  61. F Cardillo Piccolino L Borgia (1994) ArticleTitleCentral serous chorioretinopathy and indocyanine green angiography Retina 14 231–242

    Google Scholar 

  62. DR Guyer LA Yannuzzi JS Slakter JA Sorenson A Ho D Orlok (1994) ArticleTitleDigital indocyanine green angiography of central serous chorioretinopathy Arch Ophthalmol 112 1057–1062 Occurrence Handle8053819 Occurrence Handle1:STN:280:ByuA3s%2FosF0%3D

    PubMed  CAS  Google Scholar 

  63. C Prunte J Flammer (1996) ArticleTitleChoroidal capillary and venous congestion in central serous chorioretinopathy Am J Ophthalmol 121 26–34 Occurrence Handle8554078 Occurrence Handle1:STN:280:BymC2c3gsVA%3D

    PubMed  CAS  Google Scholar 

  64. U Schmidt-Erfurth S Michels I Barbazetto H Laqua (2002) ArticleTitlePhotodynamic effects on choroidal neovascularization and physiological choroid Invest Ophthalmol Vis Sci 43 830–841 Occurrence Handle11867605

    PubMed  Google Scholar 

  65. M Battaglia Parodi S Da Pozzo G Ravalico (2003) ArticleTitlePhotodynamic therapy in chronic central serous chorioretinopathy Retina 23 235–237 Occurrence Handle12707605 Occurrence Handle1:STN:280:DC%2BD3s3it1Cquw%3D%3D

    PubMed  CAS  Google Scholar 

  66. C Canakis C Livir-Rallatos Z Panayiotis et al. (2003) ArticleTitleOcular photodynamic therapy for serous macular detachment in the diffuse retinal pigment epitheliopathy variant of idiopathic central serous chorioretinopathy Am J Ophthalmol 136 750–752 Occurrence Handle10.1016/S0002-9394(03)00397-0 Occurrence Handle14516825

    Article  PubMed  Google Scholar 

  67. F Cardillo Piccolino CM Eandi L Ventre RC Rigault de la Longrais FM Grignolo (2003) ArticleTitlePhotodynamic therapy for chronic central serous chorioretinopathy Retina 23 752–763 Occurrence Handle14707823

    PubMed  Google Scholar 

  68. TY Lai WM Chan DS Lam (2004) ArticleTitleTransient reduction in retinal function revealed by multifocal electroretinogram after photodynamic therapy Am J Ophthalmol 137 826–833 Occurrence Handle15126146

    PubMed  Google Scholar 

  69. E Rechtman RP Danis LM Pratt A Harris (2004) ArticleTitleIntravitreal triamcinolone with photodynamic therapy for subfoveal choroidal neovascularisation in age-related macular degeneration Br J Ophthalmol 88 344–347 Occurrence Handle10.1136/bjo.2003.027177 Occurrence Handle14977766 Occurrence Handle1:STN:280:DC%2BD2c7ivF2itg%3D%3D

    Article  PubMed  CAS  Google Scholar 

  70. RF Spaide J Sorenson L Maranan (2003) ArticleTitleCombined photodynamic therapy with verteporfin and intravitreal triamcinolone acetonide for choroidal neovascularization Ophthalmology 110 1517–1525 Occurrence Handle12917166

    PubMed  Google Scholar 

  71. InstitutionalAuthorNameEyetech Study Group (2003) ArticleTitleAnti-vascular endothelial growth factor therapy for subfoveal choroidal neovascularization secondary to age-related macular degeneration: phase II study results Ophthalmology 110 979–986

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Ophthalmology and Visual Sciences, The Chinese University of Hong Kong, Hong Kong Eye Hospital, Kowloon, Hong Kong, China

    Wai-Man Chan, Timothy Y.Y. Lai, Kenneth K.W. Li & Dennis S.C. Lam

  2. Department of Ophthalmology and Visual Sciences, The Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, Hong Kong, China

    Wai-Man Chan, David T.L. Liu & Dennis S.C. Lam

  3. Department of Ophthalmology, Osaka University Medical School, Osaka, Japan

    Yasuo Tano

Authors
  1. Wai-Man Chan
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Timothy Y.Y. Lai
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Yasuo Tano
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. David T.L. Liu
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Kenneth K.W. Li
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Dennis S.C. Lam
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Wai-Man Chan.

About this article

Cite this article

Chan, WM., Lai, T., Tano, Y. et al. Photodynamic Therapy in Macular Diseases of Asian Populations: When East Meets West. Jpn J Ophthalmol 50, 161–169 (2006). https://doi.org/10.1007/s10384-005-0259-z

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10384-005-0259-z

Key words

Search

Navigation